PEStore

Buyout PE

MKH Capital

MKH Capital acquires controlling stakes in established, profitable businesses, from Chicago, United States. It states a focus on healthcare & life sciences and consumer & retail.

Disclosed holdings12
Earliest stated investment2020
HeadquartersChicago, United States
Stated cheque size10 - 200 million

Stated investment criteria

What MKH Capital says it buys

Read from MKH Capital’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Enterprise value it states$10m to $200m1
EBITDA it states$2m to $15m1
Transaction typesAdd-on1
OfficesMiami3
People listed on its team page102

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. MKH Capital states that it takes majority or outright ownership. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by MKH Capital to consider any particular business, and nothing on this page is represented as being for sale.

Portfolio

Disclosed holdings

Companies MKH Capital lists on its own website. 7 carry a stated investment year. 1 has a recorded transaction against it in the deal archive.

CompanyInvestedYears heldRecorded transaction
Clean Streak Ventures20206$390m 2021
Allied Universal20215
Wax Center Partners20215
Fertilitas Ventures20224
Able Kids20251
All Together Autism20251
Haven Health Management20260
Aesenpanama
Aocmetals
Cableonda
Golfchannel La
Tracestaffing

Compiled from MKH Capital’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this MKH Capital?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.